INONasdaqPharmaceutical PreparationsFiscal year ends December 31
INOVIO PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.00+0.01 (+1.00%)
Close on Oct 19, 2026
- Market cap
- $81.62M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Inovio Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 6, 2026 | Oct 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 20, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 20, 2026 | Apr 7, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2026 | Apr 6, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2026 | Apr 2, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2026 | Jan 27, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2025 | Dec 29, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 11, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 2, 2025 | Jul 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 20, 2025 | May 22, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 20, 2025 | Apr 7, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2025 | Mar 18, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2024 | Dec 16, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 21, 2024 | May 28, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 13, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2024 | Apr 17, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2023 | Apr 11, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 24, 2024 | Jan 25, 2024 | SEC EDGAR |